{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:38:55Z","timestamp":1781653135027,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s10067-008-0973-2","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T08:48:45Z","timestamp":1219222125000},"page":"1469-1471","source":"Crossref","is-referenced-by-count":45,"title":["Treatment of refractory juvenile dermatomyositis with tacrolimus"],"prefix":"10.1007","volume":"27","author":[{"given":"Jihaan","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Jaap","family":"van der Net","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"van Royen-Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,21]]},"reference":[{"key":"973_CR1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.bor.0000240362.32089.4c","volume":"18","author":"E Stringer","year":"2006","unstructured":"Stringer E, Feldman BM (2006) Advances in the treatment of juvenile dermatomyositis. Curr Opin Rheumatol 18:503\u2013506","journal-title":"Curr Opin Rheumatol"},{"key":"973_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003088-200140040-00004","volume":"40","author":"PE Wallemacq","year":"2001","unstructured":"Wallemacq PE, Verbeeck RK (2001) Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. Clin Pharmacokinet 40:283\u2013295","journal-title":"Clin Pharmacokinet"},{"key":"973_CR3","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1002\/art.11363","volume":"48","author":"DE Yocum","year":"2003","unstructured":"Yocum DE, Furst DE, Kaine JL et al (2003) Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. Arthritis Rheum 48:3328\u20133337","journal-title":"Arthritis Rheum"},{"key":"973_CR4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/ard.56.11.690","volume":"56","author":"M Duddridge","year":"1997","unstructured":"Duddridge M, Powell RJ (1997) Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. Ann Rheum Dis 56:690\u2013692","journal-title":"A report of three cases. Ann Rheum Dis"},{"key":"973_CR5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1572-0241.2006.00524.x","volume":"101","author":"DC Baumgart","year":"2006","unstructured":"Baumgart DC, Pintoffl JP, Sturm A et al (2006) Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease\u2014a long-term follow-up. Am J Gastroenterol 101:1048\u20131056","journal-title":"Am J Gastroenterol"},{"key":"973_CR6","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","volume":"353","author":"CV Oddis","year":"1999","unstructured":"Oddis CV, Sciurba FC, Elmagd KA, Starzl TE (1999) Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 353:1762\u20131763","journal-title":"Lancet"},{"key":"973_CR7","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","volume":"52","author":"MR Wilkes","year":"2005","unstructured":"Wilkes MR, Sereika SM, Fertig N et al (2005) Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52:2439\u20132446","journal-title":"Arthritis Rheum"},{"key":"973_CR8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10067-004-0865-z","volume":"23","author":"Y Shimojima","year":"2004","unstructured":"Shimojima Y, Gono T, Yamamoto K et al (2004) Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis. Clin Rheumatol 23:262\u2013265","journal-title":"Clin Rheumatol"},{"key":"973_CR9","first-page":"707","volume":"23","author":"S Ochi","year":"2005","unstructured":"Ochi S, Nanki T, Takada K et al (2005) Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis\/dermatomyositis. Clin Exp Rheumatol 23:707\u2013710","journal-title":"Clin Exp Rheumatol"},{"key":"973_CR10","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2169\/internalmedicine.44.1197","volume":"44","author":"T Mitsui","year":"2005","unstructured":"Mitsui T, Kuroda Y, Kunishige M, Matsumoto T (2005) Successful treatment with tacrolimus in a case of refractory dermatomyositis. Intern Med 44:1197\u20131179","journal-title":"Intern Med"},{"key":"973_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00431-004-1497-7","volume":"163","author":"A Yamada","year":"2004","unstructured":"Yamada A, Ohshima Y, Omata N et al (2004) Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A. Eur J Pediatr 163:561\u2013562","journal-title":"Eur J Pediatr"},{"key":"973_CR12","first-page":"727","volume":"59","author":"C Modesto","year":"2003","unstructured":"Modesto C, Boronat M, Marsal S, Arnal-Guimera C (2003) FK-506 in the treatment of unresponsive juvenile dermatomyositis. Ann Rheum Dis 59:727\u2013729","journal-title":"Ann Rheum Dis"},{"key":"973_CR13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-7753(06)72367-3","volume":"127","author":"NA Martin","year":"2006","unstructured":"Martin NA, Modesto CC, Arnal GC et al (2006) Efficacy of tacrolimus (FK-506) in the treatment of recalcitrant juvenile dermatomyositis: study of 6 cases. Med Clin (Barc) 127:697\u2013701","journal-title":"Med Clin (Barc)"},{"key":"973_CR14","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/bi048503v","volume":"44","author":"TH Davies","year":"2005","unstructured":"Davies TH, Ning YM, Sanchez ER (2005) Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry 44:2030\u20132038","journal-title":"Biochemistry"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-0973-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T13:41:30Z","timestamp":1550065290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-008-0973-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,21]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1007\/s10067-008-0973-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,21]]}}}